- Report
- October 2024
- 197 Pages
Global
From €3312EUR$3,545USD£2,802GBP
€3680EUR$3,939USD£3,113GBP
- Report
- July 2024
- 175 Pages
Global
From €4671EUR$5,000USD£3,952GBP
- Report
- November 2023
- 96 Pages
Global
From €3500EUR$4,013USD£3,065GBP
Dermatophytosis is a fungal infection of the skin, hair, and nails caused by dermatophytes. Dermatophytosis drugs are used to treat this condition. These drugs are typically antifungal medications, such as terbinafine, itraconazole, and fluconazole. They are available in both topical and oral forms. In addition, some dermatophytosis drugs are used to treat other fungal infections, such as candidiasis and tinea versicolor.
The dermatophytosis drug market is a subset of the larger dermatological drug market. It is composed of a variety of products, including antifungal medications, topical creams, and ointments. These products are used to treat a range of fungal infections, including dermatophytosis.
Some companies in the dermatophytosis drug market include Pfizer, Novartis, Merck, and Johnson & Johnson. Show Less Read more